These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24316647)

  • 41. Portraits of TET-mediated DNA hydroxymethylation in cancer.
    Jeschke J; Collignon E; Fuks F
    Curr Opin Genet Dev; 2016 Feb; 36():16-26. PubMed ID: 26875115
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cytosine modifications modulate the chromatin architecture of transcriptional enhancers.
    Mahé EA; Madigou T; Sérandour AA; Bizot M; Avner S; Chalmel F; Palierne G; Métivier R; Salbert G
    Genome Res; 2017 Jun; 27(6):947-958. PubMed ID: 28396520
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Histone methylation by the Drosophila epigenetic transcriptional regulator Ash1.
    Beisel C; Imhof A; Greene J; Kremmer E; Sauer F
    Nature; 2002 Oct; 419(6909):857-62. PubMed ID: 12397363
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells.
    Okada M; Kanamori M; Someya K; Nakatsukasa H; Yoshimura A
    Epigenetics Chromatin; 2017; 10():24. PubMed ID: 28503202
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A role for Octamer binding protein motifs in the regulation of the proximal preprotachykinin-A promoter.
    Fiskerstrand CE; Newey P; McGregor GP; Gerrard L; Millan F; Quinn JP
    Neuropeptides; 2000 Dec; 34(6):348-54. PubMed ID: 11162291
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of FGF-4 enhancer activity by transcription factor NF-Y.
    Bryans M; Lucas JM; Knobloch TJ; Wilkie NM; Lang JC
    Biochem Biophys Res Commun; 1995 Jun; 211(2):519-27. PubMed ID: 7794264
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Developmental Transcriptional Enhancers: A Subtle Interplay between Accessibility and Activity: Considering Quantitative Accessibility Changes between Different Regulatory States of an Enhancer Deconvolutes the Complex Relationship between Accessibility and Activity.
    Bozek M; Gompel N
    Bioessays; 2020 Apr; 42(4):e1900188. PubMed ID: 32142172
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epigenetic aspects of DC development and differentiation.
    Chauvistré H; Seré K
    Mol Immunol; 2020 Dec; 128():116-124. PubMed ID: 33126080
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanism of chromatin recognition and transcriptional regulation by LEF-1 and the Wnt/Wg-responsive LEF-1:beta-catenin complex.
    Tutter A; McAlpine GS; Jones KA
    Cold Spring Harb Symp Quant Biol; 1999; 64():445-52. PubMed ID: 11232320
    [No Abstract]   [Full Text] [Related]  

  • 50. The recently identified modifier of murine metastable epialleles, Rearranged L-Myc Fusion, is involved in maintaining epigenetic marks at CpG island shores and enhancers.
    Harten SK; Oey H; Bourke LM; Bharti V; Isbel L; Daxinger L; Faou P; Robertson N; Matthews JM; Whitelaw E
    BMC Biol; 2015 Mar; 13():21. PubMed ID: 25857663
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulation of chromatin accessibility for V(D)J recombination.
    Hernandez-Munain C; McMurry MT; Krangel MS
    Cold Spring Harb Symp Quant Biol; 1999; 64():183-9. PubMed ID: 11232283
    [No Abstract]   [Full Text] [Related]  

  • 52. Transcription onset of genes critical in liver carcinogenesis is epigenetically regulated by methylated DNA-binding protein MBD2.
    Stefanska B; Suderman M; Machnes Z; Bhattacharyya B; Hallett M; Szyf M
    Carcinogenesis; 2013 Dec; 34(12):2738-49. PubMed ID: 23955541
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human follicle-stimulating hormone receptor (FSH-R) promoter/enhancer activity is inhibited by transcriptional factors, from the upstream stimulating factors family, via E-box and newly identified initiator element (Inr) in FSH-R non-expressing cells.
    Putowski LT; Schillings WJ; Lee CM; Reddy EP; Jakowicki JA
    Gynecol Endocrinol; 2004 Jul; 19(1):9-17. PubMed ID: 15625767
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells.
    Zhao MT; Shao NY; Hu S; Ma N; Srinivasan R; Jahanbani F; Lee J; Zhang SL; Snyder MP; Wu JC
    Circ Res; 2017 Nov; 121(11):1237-1250. PubMed ID: 29030344
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gene expression regulation and cancer.
    Delgado MD; León J
    Clin Transl Oncol; 2006 Nov; 8(11):780-7. PubMed ID: 17134965
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pi 1 binding sites are negative regulators of bcl-2 expression in pre-B cells.
    Chen HM; Boxer LM
    Mol Cell Biol; 1995 Jul; 15(7):3840-7. PubMed ID: 7791791
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [In vitro modelling of the interactions between the promoter and enhancer complexes].
    Kondrashov AV; Pospelov VA
    Tsitologiia; 2001; 43(8):764-71. PubMed ID: 11601392
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Altering chromatin methylation patterns and the transcriptional network involved in regulation of hematopoietic stem cell fate.
    Shokouhian M; Bagheri M; Poopak B; Chegeni R; Davari N; Saki N
    J Cell Physiol; 2020 Oct; 235(10):6404-6423. PubMed ID: 32052445
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activator proteins which regulate immunoglobulin heavy chain gene transcription in B lymphocytes.
    Roman C; Riggs K; Merrell K; Calame K
    Prog Clin Biol Res; 1990; 352():241-8. PubMed ID: 2119507
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Isolation and characterization of the human Cdc2L1 gene promoter.
    Kahle A; Feng Y; A Nelson M
    Gene; 2005 Jan; 344():53-60. PubMed ID: 15656972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.